Stathis D. Kotsakis

841 total citations
28 papers, 634 citations indexed

About

Stathis D. Kotsakis is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Stathis D. Kotsakis has authored 28 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 9 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Stathis D. Kotsakis's work include Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacterial biofilms and quorum sensing (7 papers). Stathis D. Kotsakis is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacterial biofilms and quorum sensing (7 papers). Stathis D. Kotsakis collaborates with scholars based in Greece, France and Sweden. Stathis D. Kotsakis's co-authors include Vivì Miriagou, L. S. Tzouvelekis, Εva Tzelepi, Costas C. Papagiannitsis, D. G. Joakim Larsson, Carl‐Fredrik Flach, George L. Daikos, Nachiket P. Marathe, Fanny Berglund and Evdokia Karagouni and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Environment International.

In The Last Decade

Stathis D. Kotsakis

28 papers receiving 629 citations

Peers

Countries citing papers authored by Stathis D. Kotsakis

Since Specialization

Citations

This map shows the geographic impact of Stathis D. Kotsakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stathis D. Kotsakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stathis D. Kotsakis more than expected).

Fields of papers citing papers by Stathis D. Kotsakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stathis D. Kotsakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stathis D. Kotsakis. The network helps show where Stathis D. Kotsakis may publish in the future.

Co-authorship network of co-authors of Stathis D. Kotsakis

This figure shows the co-authorship network connecting the top 25 collaborators of Stathis D. Kotsakis. A scholar is included among the top collaborators of Stathis D. Kotsakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stathis D. Kotsakis. Stathis D. Kotsakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus—Host Interactions 2022 ·Biomolecules ·(unknown), (unknown), (unknown), Stathis D. Kotsakis, Urania Georgopoulou, Pelagia Foka	3
2	Structural and biochemical characterization of the environmental MBLs MYO-1, ECV-1 and SHD-1 2020 ·Journal of Antimicrobial Chemotherapy ·Christopher Fröhlich, Vidar Sørum, Sandra Huber, Ørjan Samuelsen, Fanny Berglund, Erik Kristiansson, Stathis D. Kotsakis, Nachiket P. Marathe, D. G. Joakim Larsson, Hanna‐Kirsti S. Leiros	8
3	Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019 2020 ·Eurosurveillance ·Evangelia Voulgari, Stathis D. Kotsakis, Παναγιώτα Γιαννοπούλου, Efstathia Perivolioti, L. S. Tzouvelekis, Vivì Miriagou	25
4	A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB/c Mice Infected with Leishmania infantum 2020 ·Vaccines ·Maria Agallou, Maritsa Margaroni, Stathis D. Kotsakis, Evdokia Karagouni	22
5	Functional metagenomics reveals a novel carbapenem-hydrolyzing mobile beta-lactamase from Indian river sediments contaminated with antibiotic production waste 2018 ·Environment International ·Nachiket P. Marathe, Anders Janzon, Stathis D. Kotsakis, Carl‐Fredrik Flach, Mohammad Razavi, Fanny Berglund, Erik Kristiansson, D. G. Joakim Larsson	44
6	Identification of 76 novel B1 metallo-β-lactamases through large-scale screening of genomic and metagenomic data 2017 ·Microbiome ·Fanny Berglund, Nachiket P. Marathe, Tobias Österlund, Johan Bengtsson‐Palme, Stathis D. Kotsakis, Carl‐Fredrik Flach, D. G. Joakim Larsson, Erik Kristiansson	65
7	Comparison of Short Versus Prolonged Infusion of Standard Dose of Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae Isolates in Different Patient Groups: A Pharmacokinetic–Pharmacodynamic Approach 2016 ·Journal of Pharmaceutical Sciences ·Sophia Vourli, (unknown), Stathis D. Kotsakis, George L. Daikos, L. S. Tzouvelekis, Vivì Miriagou, Loukia Zerva, Joseph Meletiadis	17
8	Identification of CMY-2-Type Cephalosporinases in Clinical Isolates of Enterobacteriaceae by MALDI-TOF MS 2014 ·Antimicrobial Agents and Chemotherapy ·Costas C. Papagiannitsis, Stathis D. Kotsakis, Zdeněk Tůma, Marek Gniadkowski, Vivì Miriagou, Jaroslav Hrabák	14
9	Laboratory evaluation of Brilliance™ CRE Agar for screening carbapenem-resistant Enterobacteriaceae: Performance on a collection of characterised clinical isolates from Greece 2013 ·Journal of Global Antimicrobial Resistance ·Stathis D. Kotsakis, Efthymia Petinaki, (unknown), (unknown), Vivì Miriagou, Εva Tzelepi	6
10	Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers 2013 ·Clinical Microbiology and Infection ·Vivì Miriagou, Εva Tzelepi, Stathis D. Kotsakis, George L. Daikos, (unknown), L. S. Tzouvelekis	35
11	OmpK35 and OmpK36 porin variants associated with specific sequence types ofKlebsiella pneumoniae 2013 ·Journal of Chemotherapy ·Costas C. Papagiannitsis, Panagiota Giakkoupi, Stathis D. Kotsakis, Εva Tzelepi, L. S. Tzouvelekis, Alkiviadis Vatopoulos, Vivì Miriagou	21
12	Interactions of Oximino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 2012 ·Antimicrobial Agents and Chemotherapy ·Stathis D. Kotsakis, Emilia Caselli, L. S. Tzouvelekis, Efi Petinaki, Fabio Prati, Vivì Miriagou	11
13	Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to β-lactams 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·Stathis D. Kotsakis, L. S. Tzouvelekis, Loukia Zerva, Apostolos Liakopoulos, Efthymia Petinaki	6
14	CMY-42, a Novel Plasmid-Mediated CMY-2 Variant AmpC Beta-Lactamase 2011 ·Microbial Drug Resistance ·Moritz Hentschke, Stathis D. Kotsakis, Manuel Wolters, Peter Heisig, Vivì Miriagou, Martin Aepfelbacher	32
15	Effects of the Val211Gly substitution on molecular dynamics of the CMY‐2 cephalosporinase: Implications on hydrolysis of expanded‐spectrum cephalosporins 2011 ·Proteins Structure Function and Bioinformatics ·Stathis D. Kotsakis, L. S. Tzouvelekis, Efthymia Petinaki, Εva Tzelepi, Vivì Miriagou	8
16	Characterization of Metallo-β-Lactamase VIM-27, an A57S Mutant of VIM-1 Associated with Klebsiella pneumoniae ST147 2011 ·Antimicrobial Agents and Chemotherapy ·Costas C. Papagiannitsis, Stathis D. Kotsakis, Efthymia Petinaki, Alkiviadis Vatopoulos, Εva Tzelepi, Vivì Miriagou, L. S. Tzouvelekis	24
17	Comparative Biochemical and Computational Study of the Role of Naturally Occurring Mutations at Ambler Positions 104 and 170 in GES β-Lactamases 2010 ·Antimicrobial Agents and Chemotherapy ·Stathis D. Kotsakis, Vivì Miriagou, Εva Tzelepi, L. S. Tzouvelekis	39
18	Sequence of pNL194, a 79.3-Kilobase IncN Plasmid Carrying the bla _VIM-1 Metallo-β-Lactamase Gene in Klebsiella pneumoniae 2010 ·Antimicrobial Agents and Chemotherapy ·Vivì Miriagou, Costas C. Papagiannitsis, Stathis D. Kotsakis, (unknown), Εva Tzelepi, N.J. Legakis, L. S. Tzouvelekis	42
19	Extended-Spectrum Properties of CMY-30, a Val211Gly Mutant of CMY-2 Cephalosporinase 2009 ·Antimicrobial Agents and Chemotherapy ·Stathis D. Kotsakis, Costas C. Papagiannitsis, Εva Tzelepi, L. S. Tzouvelekis, Vivì Miriagou	17
20	CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids 2008 ·Antimicrobial Agents and Chemotherapy ·(unknown), Jean M. Whichard, Stathis D. Kotsakis, L. S. Tzouvelekis, Εva Tzelepi, Vivì Miriagou	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact